Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
Revolutionize drug development with AI-driven insights. Enhance portfolio strategy, reduce risks, and make informed decisions. Our solutions predict success.
News
Intelligencia AI Named to the Inc. 5000 2026 List of America's Fastest-Growing Private Companies
Intelligencia AI is proud to announce its inclusion on the 2026 Inc. 5000 list for the third consecutive year, ranking among America's fastest-growing private companies. The company was also recognized within the Artificial Intelligence and Data industry,
Read more
Report
The Insight Drop B7-H3 (CD276): The ADC Race to Unlock a High-Momentum Target
(How a 20-year-old target became a 2021-onward surge, why early modalities stalled, and what it will take to convert momentum into approvals) TL;DR B7-H3 has moved from a long-standing biological hypothesis to a high-momentum clinical target, with the sur
Read more
Report
Intelligencia AI - Industry Partners Boston Roundtable
We will be hosting an executive roundtable in Boston with industry leaders to discuss the evolving challenges of clinical development.It will be a great opportunity to exchange perspectives, explore emerging trends, and hear firsthand how teams across the
Read more
Report
Clinical Success Is No Longer One Number
By Andreas Dimakakos, Director of Clinical Data; Kate Smietana, Director, Knowledge and Thought Leadership; Panos Karelis, VP of Commercial; and Dimitris Skaltsas, Co-founder & CEO TL;DR Traditional drug development benchmarks measure overall success rate
Read more
Report
The Insight Drop Oral GLP-1: The Next Distribution Shift-But Not the Torch Pass Yet
TL;DR Oral GLP-1 is no longer theoretical: multiple approvals and a growing Phase 3 pipeline signal a real market transition. Injectables still dominate the category: they retain the advantage in efficacy, late-stage maturity, and clinical confidence. The
Read more
Report
Pro access
Upgrade to see all 17 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.